Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.
Thread quality is excellent — keep it up. 👍
Slightly tangential to Mounjaro KwikPen vs vial but Dr.GastroMayo reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
DerekSJ_a1c said:Follow-up question: what labs did your doctor order to monitor this
This is exactly right. DerekSJ_a1c articulated what I have been trying to explain to my friends for months. The Mounjaro KwikPen vs vial aspect is what made the difference for me.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsSaving this for reference. Quality thread.
Adding my data to this Mounjaro KwikPen vs vial discussion:
| Metric | Baseline | Month 4 | Month 6 |
|---|---|---|---|
| Weight | 260 lbs | 225 lbs | 205 lbs |
| A1C | 6.4% | 6.2% | 5.2% |
| hsCRP | 4.0 | 3.0 | 1.0 |
Protocol: Tirzepatide 15mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.